GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Intermune, Inc. (ITMN) [hlAlert]

Rating:
Buy ITMN
up 119.28 %

Intermune, Inc. (ITMN) rated Buy with price target $46 by Canaccord Genuity

Posted on: Wednesday,  Feb 26, 2014  10:25 AM ET by Canaccord Genuity

Canaccord Genuity rated Buy Intermune, Inc. (NASDAQ: ITMN) on 02/26/2014, when the stock price was $33.70. Since
then, Intermune, Inc. has gained 119.29% as of 09/26/2014's recent price of $73.90.
If you would have followed this Canaccord Genuity's recommendation on ITMN, you would have gained 119.28% of your investment in 212 days.

InterMune Pharmaceuticals Inc. develops and commercializes innovative products for the treatment of serious pulmonary and infectious diseases and congenital disorders. The company markets ACTIMMUNE for chronic granulomatous disease and osteopetrosis. The company has active development programs underway for the other disease areas, several of which are in mid-or advanced-stage human testing, known as clinical trials.

Canaccord Genuity’s global team of over 100 research professionals are inquisitive, experienced and committed to generating actionable investment ideas. We analyze over 725 companies in a broad range of market sectors, identifying value and defining risk for our clients.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/26/2014 10:25 AM Buy
None
33.70 46.00
as of 10/17/2014
1 Week   
1 Month up  0.20 %
3 Months up  82.03 %
1 YTD up  401.62 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/14/2014 11:25 AM Buy
None
17.77 22.00
7/25/2013 1:25 PM Buy
None
14.43 17.00
11/8/2012 12:25 PM Buy
None
9.40 13.00
7/24/2012 8:25 AM Hold
None
9.43 11.00
7/6/2011 9:25 AM Buy
None
36.18 44.00
12/17/2010 10:25 AM Buy
None
29.44 38.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy